Biomerica, Inc.BMRANASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-31.39%
↓ 657% below average
Average (9y)
5.64%
Historical baseline
Range
High:44.89%
Low:-31.39%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2025 | -31.39% |
| 2024 | -5.87% |
| 2023 | -12.60% |
| 2022 | -17.41% |
| 2021 | 14.88% |
| 2020 | 13.76% |
| 2019 | 20.08% |
| 2018 | 23.68% |
| 2017 | 44.89% |
| 2016 | 6.36% |